Company Spotlight

Adare Pharma Solutions

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


CNS Contract Research Corp





Company Headquarters

550 University Ave
NRC Bldg. Suite 508
Charlottetown, PE C1A 4P3
Canada

Contract Service Directory

    Related Content

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      AC Immune and WuXi Biologics Expand Strategic Partnership

      AC Immune and WuXi Biologics Expand Strategic Partnership

      Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.
      Contract Pharma Staff 11.10.20

    • Drug Delivery | Drug Development | Trials & Filings
      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Leverages the company’s Precision Olfactory Delivery technology
      11.09.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
      Sai Life Sciences to Expand Biology Capabilities

      Sai Life Sciences to Expand Biology Capabilities

      Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.
      Contract Pharma Staff 10.28.20


    • Breaking News | Clinical Trials
      CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

      CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

      Phase 2 trial will commence during the first quarter of 2021.
      Contract Pharma Staff 10.20.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B

      Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B

      Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ gene therapy capabilities.
      Contract Pharma Staff 10.14.20

    • APIs | Breaking News | Industry News
      NCK A/S Receives CoA for Berubicin API

      NCK A/S Receives CoA for Berubicin API

      CNS has a contract with NCK A/S for the large-scale production of Berubicin, its lead drug candidate for the treatment of glioma brain tumors.
      Contract Pharma Staff 10.01.20


    • Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      LSNE, Selecta Biosciences Form Mfg. Pact

      LSNE, Selecta Biosciences Form Mfg. Pact

      LSNE to provide drug substance manufacturing and fill/finish services
      05.24.17

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis SA and OSE Immunotherapeutics Enter Pact

      Selexis SA and OSE Immunotherapeutics Enter Pact

      Sign agreement for the development of OSE's interleukin receptor 7 antagonist
      05.24.17

    • Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
      Nektar and Takeda in Research Collaboration

      Nektar and Takeda in Research Collaboration

      Will explore combination cancer therapies
      05.22.17


    • Clinical Trials | CRO News

      PSI CRO to Open New Office in Durham

      Aims to offer an ideal collaborative setting for both clients and staff in RTP
      05.10.16

    • Breaking News | Drug Development | Formulation Development | Industry News | Methods Development

      Sanofi Licenses Ligand’s Captisol Technology

      Will use Captisol in the development and commercialization of cancer therapy SAR-125844
      07.30.15

    • Breaking News | Clinical Trials | Drug Development | Financial Reports

      Financial Report: INC Research

      Revenues up 14% in the quarter
      07.30.15


    • Breaking News | Clinical Trials | Drug Development | Industry News | R&D

      Novartis Acquires Spinifex Pharmaceuticals

      Expands neuroscience portfolio with novel angiotensin II type 2 receptor antagonist for the treatment of chronic pain
      07.01.15

    • Breaking News | Financial Reports

      Financial Report: INC Research 1Q

      Service revenues up 15%
      04.28.15